𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunogenicity of two different dosages (10 and 5 μg) of recombinant DNA hepatitis B vaccine in healthy neonates

✍ Scribed by R. del Canho; P.M. Grosheide; M. Voogd-Schotanus; W.M. Huisman; R.A. Heijtink; S.W. Schalm

Book ID
119528949
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
447 KB
Volume
12
Category
Article
ISSN
0264-410X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity of 20 μg of recombinant D
Immunogenicity of 20 μg of recombinant DNA hepatitis B vaccine in healthy neonates: A comparison of three different vaccination schemes
✍ R. Del Canho; P. M. Grosheide; M. Voogd; W. M. Huisman; R. A. Heijtink; Dr. S. W 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

## Abstract The immunogenicity of a full dose (20 μg) of recombinant DNA yeast‐derived hepatitis B vaccine (Engerix‐B) was assessed in healthy neonates in order to compare three candidate vaccination schemes. After randomization 162 newborns of hepatitis B surface antigen (HBsAg) negative mothers e

Recombinant-yeast-derived hepatitis b va
Recombinant-yeast-derived hepatitis b vaccine in healthy adults: Safety and two-year immunogenicity of early investigative lots of vaccine
✍ Lynn Butterly; Eloise Watkins; Jules L. Dienstag 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 554 KB

We tested the safety and long-term immunogenicity of two of the early investigative lots of a recombinant-yeast-derived hepatitis B vaccine in immunocompetent adults. Three 10-micrograms doses of recombinant hepatitis B vaccine (Merck Sharp & Dohme Research Laboratories, West Point, PA) were adminis